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Purpose:  Light-induced  retinal  degeneration  is  a  vision-threatening  retinal  disease.  Light  can  damage  not  only
photoreceptor cells but also retinal ganglion cells (RGCs). This study was aimed to observe the spatiotemporal expression
of dexamethasone-induced Ras protein 1 (Dexras1) and document the effect of Dexras1 on RGC damage after light
exposure.
Methods: Adult Sprague-Dawley rats were exposed to bright white light for 2 h. Reverse transcriptase-PCR (RT–PCR)
and western blot analysis were used to analyze mRNA and protein expression of Dexras1. The spatial distribution of
Dexras1 and outer nuclear layer (ONL) thickness were evaluated by immunohistochemistry. Immunoﬂuorescence was
performed to observe the colocalization of Dexras1. In addition, cell apoptosis in this model was measured using terminal
deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL). Finally, the effect of systemic
administration of nitric oxide synthase (NOS) inhibitor on the retina was investigated by western blot analysis and
immunoﬂuorescence.
Results: Dexras1 expression increased at 6 h and reached the peak at 1 day, gradually recovering to the baseline level at
7 days after light exposure. Dexras1 immunoreactivity was detected in RGCs and colabeled with cleaved caspase-3 after
light  exposure,  whereas  cleaved  caspase-3  immunoreactivity  was  undetectable  in  the  ONL.  However,
immunohistochemistry demonstrated that the ONL thickness decreased after light exposure and TUNEL revealed that
photoreceptor cell apoptosis also occurred. In addition, the ternary complex of Dexras1, neuronal NOS (nNOS), and the
C-terminal PSD95/DLG/ZO-1 ligand of nNOS was observed in RGCs. Administration of NOS inhibitor decreased the
expression of cleaved caspase-3 and Dexras1.
Conclusions: Exposure to light caused the transient high expression of Dexras1, which was colabeled with apoptotic
marker, nNOS, and the C-terminal PSD95/DLG/ZO-1 ligand of nNOS in RGCs. Administration of the NOS inhibitor
prevented RGC apoptosis by decreasing cleaved caspase-3 and Dexras1 expression. Dexras1-mediated RGC damage
appears to act through activation of nNOS in this model.
The human retina is protected from shorter wavelength
radiation by the cornea and lens, which absorb ultraviolet light
below 400 nm [1]. The retina is therefore exposed mainly to
the “visible component” of light. Light is an additional factor
that can lead to retinal damage. Light-induced retinal damage
has been used as a model to study retinal degeneration [2-5],
which has an important feature: photoreceptor cell death by
apoptosis [6]. However, ganglion cells, which are densely
laden with mitochondria and contain photopigment, might
also  be  susceptible  to  excessive  light  injury  [7].  Recent
findings  show  that  excessive  light  can  negatively  affect
ganglion cell survival directly in vivo and in vitro [7,8].
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The  molecular  mechanism  of  light-induced  retinal
ganglion cell (RGC) damage remains unclear. Nitric oxide
(NO) plays critical roles in the eye at various physiologic
levels [9] but leads to neuronal cell death when produced in
excess [10]. NO is synthesized by a group of isoenzymes
known  as  NO  synthase  (NOS),  which  consists  of  three
members:  neuronal  NOS  (nNOS),  inducible  NOS,  and
endothelial  NOS  [11,12].  In  the  light-induced  retinal
degeneration model, the results reveal no detectable increase
in either inducible NOS or endothelial NOS expression; only
nNOS expression increases significantly after light damage
[13]. nNOS, a calcium (Ca2+)/calmodulin-dependent enzyme,
is reported to be induced in many pathological processes,
including RGC apoptosis [14]. One of the regulators of nNOS
is  the  N-methyl-D-aspartate  receptor  (NMDAR),  an
excitatory  glutamate  receptor  consisting  of  N-methyl-D-
aspartate receptor 1 (NMDAR1 or NR1) and N-methyl-D-
aspartate  receptor  2  (NMDAR2  or  NR2)  subunits  that  is
targeted to excitatory synapses, where it functions in neural
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134plasticity [15]. In neurons, stimulation of NMDAR activates
nNOS,  leading  to  S-nitrosylation  and  activation  of
dexamethasone-induced Ras protein 1 (Dexras1) [16].
Dexras1 is a 30 kDa G protein in the Ras subfamily whose
discovery was based on its pronounced inducibility by the
glucocorticoid  dexamethasone.  It  shares  about  35%
homology with the Ras subfamily of proteins and contains all
of the conserved domains of typical guanosine triphosphatase
(GTPases). Similar to other members of the Ras subfamily,
Dexras1 possesses four highly conserved motifs for GTP-
binding  and  hydrolysis,  an  effector  loop  that  mediates
protein–protein  interactions,  and  a  membrane-targeting
CAAX (C is a cysteine, the two A residues are aliphatic amino
acids and the X can be one of several amino acids) box, which
serves  as  a  consensus  site  for  isoprenylation.  Unlike
conventional GTPases, Dexras1 contains an extended 7 kDa
C-terminal cationic domain [17]. Dexras1 was identified as a
binding partner for the C-terminal PSD95/DLG/ZO-1 ligand
of nNOS (CAPON), a scaffolding protein that interacted with
nNOS [18]. The existence of ternary complexes of Dexras1,
nNOS, and CAPON was confirmed in the brain and spinal
cord  [19,20].  Several  studies  indicated  that  Dexras1  is  a
downstream physiologic target of nNOS-mediated signaling
[20,21].
The present investigations were designed to detect the
temporal and spatial patterns of Dexras1 expression, as well
as its cellular localization, possible role in RGC death, and
association  with  nNOS  and  CAPON  after  light  exposure.
Finally, we demonstrated the effect of the NOS inhibitor on
cleaved caspase-3 and Dexras1 expression.
METHODS
Animals: Adult Sprague-Dawley rats, either sex (Department
of Animal Center, Medical College, Nantong University),
were used in our experiments. Rats weighing 180–220 g were
kept on a 12 h:12 h light-dark schedule and given food and
water in a pathogen-free area. All experimental procedures
were  performed  in  accordance  with  the  Association  for
Research in Vision and Ophthalmology Statement for the Use
of Animals in Ophthalmic and Vision Research.
Light damage: Before light exposure, rats were dark adapted
for 1 day. After pupil dilation with compound tropicamide
(Santen  Pharmaceutical,  Osaka,  Japan),  dark-adapted  rats
were placed in cages and exposed to white light (16,000 lx)
for as long as 2 h, beginning at 9 AM During light exposure,
the room temperature was kept at 24 °C and the animals had
free access to food and water. After light exposure, all rats
were returned to darkness.
Intraperitoneal  injections:  Rats  were  injected
intraperitoneally with the following: the nonspecific NOS
inhibitor  NG-nitro-L-arginine  methyl  ester  (L-NAME),
100 mg/kg (Sigma, St. Louis, MO) in PBS (145 mM NaCl,
24  mM  Na2HPO4,  1.2  mM  NaH2PO4)  or  PBS  alone  as  a
control.  All  intraperitoneal  injections  were  administered
immediately after light exposure.
Total RNA isolation and semiquantitative RT–PCR: Total
RNA was extracted from retinas with TRIzol (Invitrogen,
Paisley,  UK).  RNA  was  reverse-transcribed  using  the
moloney  murine  leukemia  virus  (M-MLV)  reverse
transcriptase PCR system (RT–PCR; Promega, Southampton,
UK). cDNA was equalized in an amplification reaction with
Dexras1 primers (forward, 5′-GCT TAG ACA ACC GCG
ACT CCT TC-3′; reverse, 5′-CTC AAT CTC CCG CTG CTC
CAC TT-3′), yielding a 173 bp product. PCR amplification
was performed with an initial denaturing step at 94 °C for 3
min, then 30 cycles at 94 °C for 45 s, 59 °C for 45 s, 72 °C for
1 min, and a further extension at 72 °C for 7 min.
Western blot analysis: Total protein was obtained by lysing
in a buffer containing 1 M Tris-HCl pH 7.5, 1% Triton X-100,
1% NP-40 (nonidet p-40), 10% sodium dodecyl sulfate, 0.5%
sodium  deoxycholate,  0.5  M  EDTA,  10  μg/ml  leupeptin,
10  μg/ml  aprotinin,  and  1  mM  phenylmethanesulfonyl
fluoride  or  phenylmethylsulfonyl  fluoride.  Protein  was
separated with sodium dodecyl sulfate- PAGE and transferred
to  polyvinylidine  difluoride  filter  membranes  (Millipore,
Bedford,  MA).  The  membranes  were  incubated  overnight
with Dexras1 (Santa Cruz Biotechnology, Santa Cruz, CA) or
cleaved caspase-3 (Cell Signaling Technology, Danvers, MA)
at 4 °C. Finally, appropriate secondary antibodies conjugated
to horseradish peroxidase were subsequently added and the
films were visualized using an enhanced chemiluminescence
system (Pierce Company, Minneapolis, MN).
Sections and immunohistochemistry: After adult rats were
anesthetized  and  perfused,  the  superior  conjunctiva  was
sutured with 8.0 vicryl as a reference that provided orientation
[22]. The eyes were fixed in 4% paraformaldehyde solution,
followed by immersion in sucrose solution for cryoprotection.
Then  the  tissues  were  embedded  in  opti-mum  cutting
temperature (OCT) compound and 8 μm frozen sections were
prepared. The superior hemisphere along the vertical meridian
was chosen in this experiment. Sections were blocked with
10% normal serum blocking solution and incubated overnight
at  4  °C  with  Dexras1.  Then,  slides  were  incubated  in
biotinylated secondary antibody, followed by incubation in
the  complex  avidin-biotin-peroxidase.  In  negative  control
sections, the primary antibody was substituted by PBS. The
reaction product was revealed by 0.02% diaminobenzidine
tetrahydrochloride.
Terminal deoxynucleotidyl transferase-mediated dUTP nick
end  labeling:  TUNEL  staining  was  performed  using  the
DeadEnd™  Fluorometric  TUNEL  System  (Promega,
Madison, WI). Frozen tissue sections were rinsed in PBS and
treated with 1% Triton X-100 in PBS for 2 min on ice. Slides
were equilibrated with equilibration buffer and then incubated
for  60  min  at  37  °C  with  recombinant  terminal
deoxynucleotidyl transferase (rTdT) incubation buffer. The
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135negative  control  sections  were  incubated  with  control
incubation buffer without the rTdT enzyme. The slides were
analyzed  using  a  Leica  TCS  SP5  confocal  microscope
(Germany).
Immunofluorescence: The sections were blocked with 1%
BSA (BSA) to avoid unspecific staining. Then, sections were
incubated overnight at 4 °C with Dexras1, CAPON (Santa
Cruz  Biotechnology,  Santa  Cruz,  CA),  nNOS  (Abcam,
Cambridge,  MA),  cleaved  caspase-3,  and  neuronal  nuclei
(NeuN;  Chemicon  International,  Temecula,  CA).  After
washing in PBS, a mixture of fluorescein isothiocyanate- and
Cy3-conjugated secondary antibodies was added. The images
were captured by Leica fluorescence microscope (Germany).
Statistical  analysis:  All  values  were  expressed  as  means
±standard error of mean (SEM). The statistical significance
of difference between groups was determined by one-way
ANOVA (ANOVA) followed by Tukey’s post hoc multiple
comparison tests. p<0.05 was considered significant.
RESULTS
Changes in mRNA and protein expression for Dexras1 after
light exposure: Semiquantitative RT–PCR was performed to
investigate  the  temporal  pattern  of  Dexras1  mRNA
expression after light exposure. We found that mRNA for
Dexras1 was relatively low in the normal retina, increased
beginning at 6 h after light exposure (p<0.05) and reached the
peak at 1 day, gradually recovering to the baseline level at 7
days (Figure 1A,B). In comparison with RT–PCR analysis,
we performed western blot analysis to detect Dexras1 protein
expression. The trends of Dexras1 protein expression were
similar to that of Dexras1 mRNA expression. At 6 h after light
exposure, Dexras1 protein expression increased, reached the
peak at 1 day, and then gradually declined from 3 to 7 days
(Figure 2A,B).
Distribution of Dexras1 and change of outer nuclear layer
thickness after light exposure: Immunohistochemistry was
performed  to  observe  Dexras1  distribution  and  ONL
thickness.  Slides  were  examined  at  200×  or  400×
magnification on a Leica light microscope. Figure 3D-F show
the magnified images of Figure 3A-C, respectively. In control
sections preincubated with PBS, the expression of Dexras1
was undetectable (Figure 3A,D). In the normal retina, Dexras1
immunoreactivity was relatively low in the ganglion cell layer
(GCL; Figure 3B,E). At 1 day after light exposure, strong
Dexras1  positive  cells  increased  significantly  in  the  GCL
(Figure 3C, F) compared with the normal retina based on
quantitative study (Figure 3G). Furthermore, we evaluated the
change of ONL thickness after light exposure. In the injured
retina, ONL thickness decreased significantly compared with
Figure  1.  Dexras1  mRNA  level
upregulated  in  the  retina  after  light
exposure. A: Total RNA was extracted
from  normal  and  injured  retina  at
various times after light exposure, then
assessed by reverse transcriptase (RT)-
PCR. mRNA for Dexras1 increased at 6
h after light exposure and reached the
peak at 1 day, gradually recovering to
the baseline level at 7 days. B: Relative
mRNA level represented a ratio between
the amount of target gene and amount of
endogenous  GAPDH  control.  Groups
marked  with  an  asterisk  were
significantly different from the normal
group. The data are means±SEM (n=3,
*p<0.05).
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136the normal retina (Figure 3E,F) based on quantitative analysis
(Figure 3H).
Dexras1 colocalization with markers and TUNEL labeling
after light exposure: Immunoﬂuorescence was performed on
cryosections of the retina at 1 day after light exposure. The
labeling was examined using a Leica ﬂuorescence microscope
at 400× magnification. The expression of Dexras1 in the retina
was detected by the anti-Dexras1 primary antibody (Figure
4A). NeuN (a neuron marker) was used here as the marker of
the  ganglion  cell  (Figure  4B).  Dexras1  immunoreactivity
overlapped with NeuN-positive neurons (Figure 4C). Based
on evidence that caspase-3 activity has a positive correlation
with  RGC  apoptosis  after  light  exposure  [8],  cleaved
caspase-3 was used here as an apoptotic marker to investigate
whether  apoptosis  occurred  in  Dexras1-positive  cells.
Colocalization  of  cleaved  caspase-3  and  Dexras1
demonstrated that cell apoptosis occurred in Dexras1-positive
cells (Figure 4D-F). It was interesting to find that cleaved
caspase-3 immunoreactivity was not detected in the ONL.
With the objective of elucidating whether photoreceptor cell
apoptosis occurred, we used TUNEL labeling to show cell
apoptosis in our model. In the control and normal retina, there
were no TUNEL-positive cells (Figure 4G,H). At 1 day after
light exposure, TUNEL labeling was apparent in the ONL,
inner nuclear layer (INL), and GCL (Figure 4I).
Colocalization of Dexras1, nNOS, and CAPON after light
exposure: To investigate whether Dexras1 was associated
with neuronal nitric oxide synthase (nNOS) and C-terminal
PSD95/DLG/ZO-1 ligand of neuronal nitric oxide synthase
(CAPON)  during  the  pathological  process  after  light
exposure, immunofluorescence was used on sections of the
retina  at  1  day  after  light  exposure.  nNOS  and  CAPON
immunoreactivity  overlapped  with  NeuN-positive  neurons
(data  not  shown).  Colocalization  of  nNOS  and  Dexras1
appeared in RGCs (Figure 5A-C). nNOS immunoreactivity
could be colocalized with CAPON immunoreactivity in RGCs
(Figure 5D-F). Dexras1 expression and CAPON expression
were  also  colabeled  in  RGCs  (Figure  5G-I).  These
observations showed that colocalization of Dexras1, nNOS,
and CAPON was present in RGCs.
Effects of NOS inhibitor NG-nitro-L-arginine methyl ester on
the expression of cleaved caspase-3 and Dexras1: We next
examined the effect of the administration of the NOS inhibitor
L-NAME on the retina after light exposure. Adult rats were
treated with L-NAME or PBS as a control immediately after
light exposure. Western blot analysis showed that cleaved
caspase-3 expression was undetectable in the normal retina,
increased obviously at 1 day after light exposure in the PBS-
treated group, and declined significantly at 1 day after light
exposure  in  the  L-NAME-treated  group  (Figure  6A,C).
Dexras1 expression was relatively low in the normal retina,
increased obviously at 1 day after light exposure in the PBS-
treated group, and declined significantly in the L-NAME-
treated  group  (Figure  6B,D).  Furthermore,
immunofluorescence was performed to detect the colabeling
of cleaved caspase-3 and Dexras1 decreased in the retina at 1
day after light exposure in the L-NAME-treated group (Figure
6H-J) compared with the PBS-treated group (Figure 6E-G).
Figure  2.  Dexras1  protein  level
upregulated  in  the  retina  after  light
exposure.  A:  Total  protein  was
extracted  from  normal  and  injured
retinas  at  various  times  after  light
exposure, then assessed by western blot
analysis.  B:  Relative  protein  level
represented a ratio between the amount
of  target  gene  and  amount  of
endogenous  glyceraldehyde-3-
phosphate  dehydrogenase  (GAPDH)
control. Groups marked with an asterisk
were  significantly  different  from  the
normal  group.  The  data  are  means
±standard  error  of  mean  (SEM;  n=5,
*p<0.05).
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137DISCUSSION
In addition to photoreceptor cell damage, excessive light can
result in degenerative alterations in the inner retina, as well as
ganglion  cell  death  [23-25].  Light  has  a  direct  effect  on
ganglion cell damage [7]. Given that nNOS participates in the
pathological  progress  of  RGC  damage  [14,26],  we  were
interested in investigating whether Dexras1 contributes to
RGC death in the light damage model.
In this report, we delineated that light-induced Dexras1
upregulated significantly at mRNA and protein expression in
the retina. Changes in Dexras1 mRNA and protein expression
shared  the  similar  temporal  pattern  that  Dexras1  was
constitutively expressed in the normal retina and reached the
peak at 1 day after light exposure, gradually recovering to the
baseline level at 7 days. If this is the case, the transient high
Figure 3. The distribution of Dexras1 expression and the change in outer nuclear layer thickness after light exposure. Slides were examined
at 200× or 400× magnification on a Leica light microscope. Dexras1 expression and outer nuclear layer (ONL) thickness were observed in
sections of A: negative control retina (primary antibody was substituted by PBS), B: normal retina, and C: injured retina at 1 day after light
exposure by immunohistochemistry. D-F: Magnified images for A-C, respectively, are represented. G: Quantitative results for numbers of
Dexras1 positive cells are at a lower magnification. H: Quantitative analysis of ONL thickness between the normal retina and injured retina
was conducted. Values are expressed as mean±SEM (n=3 animals, 6 eye samples from three animals for each group, *p<0.05). Abbreviations:
GCL represents ganglion cell layer; INL represents inner nuclear layer; ONL represents outer nuclear layer.
Molecular Vision 2011; 17:134-143 <http://www.molvis.org/molvis/v17/a17> © 2011 Molecular Vision
138expression of Dexras1 may provide a new insight into the
molecular mechanism of retinal light damage.
Our experiment is the first to show the spatial distribution
of Dexras1 in the retina by immunohistochemistry. These
results demonstrated that Dexras1 immunoreactivity appeared
in the GCL at a relatively low level. At 1 day after light
exposure, Dexras1 expression increased significantly in the
GCL.  Furthermore,  immunofluorescence  revealed  that  the
Dexras1  expression  localized  in  RGCs  was  confirmed  by
NeuN. This indicates that Dexras1 may be involved in RGC
damage after light exposure.
Caspases,  which  are  important  mediators  of  neuronal
apoptosis, have been demonstrated to play a critical role in
pathological cell death in the nervous system [27]. Caspase
activation has been shown in retinal degeneration in several
animal models [28,29]. In this study, Dexras1 colocalized
Figure 4. Dexras1 colocalization with markers and terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick end labeling
(TUNEL) labeling after light exposure. Immunoﬂuorescence was performed to observe Dexras1 colocalization in the retina at 1 day after light
exposure. The neuronal nuclei (NeuN) was used here as the marker of ganglion cells. A-C: Dexras1 immunoreactivity overlapped with NeuN-
positive neurons in the retina. D-F: Cleaved caspase-3 as an apoptotic marker was colocalized in Dexras1-positive cells in the retina. C, F:
Merged images. Magnification, 400×. TUNEL results were observed in sections of G: control retina, H: the normal retina, and I: the injured
retina at 1 day after light exposure. In the control and normal retina, there were no TUNEL-positive cells. In the injured retina at 1 day after
light exposure, TUNEL-positive labeling was apparent in the ONL, INL, and GCL. The scale bar is 50 µm in G-I. Abbreviations: GCL
represents ganglion cell layer; INL represents inner nuclear layer; ONL represents outer nuclear layer.
Molecular Vision 2011; 17:134-143 <http://www.molvis.org/molvis/v17/a17> © 2011 Molecular Vision
139with the apoptotic marker (cleaved caspase-3) in RGCs. These
results showed that light-induced RGC apoptosis could be
mediated by Dexras1.
Consensus indicates that exposure to excessive levels of
light  results  in  photoreceptor  cells  apoptosis  [6,30,31].
Interestingly,  we  observed  that  cleaved  caspase-3
immunoreactivity was undetectable in photoreceptor cells.
However,  we  showed  that  ONL  thickness  decreased
significantly after light exposure compared with the normal
retina, which was consistent with previous studies [22,32,
33].  Furthermore,  TUNEL  labeling  showed  that  TUNEL-
positive cells were present in the ONL, INL, and GCL. These
data support the idea that photoreceptor cells also undergo
apoptosis in this model. A possible explanation for this is that
photoreceptor  cells  do  not  experience  caspase-dependent
apoptosis. In fact, the caspase-independent apoptotic pathway
in photoreceptor cells has been well reported [13,34,35]. A
steadily increasing number of reports suggest that not all cell
types require caspase activity to undergo apoptosis [36,37].
These  observations  demonstrate  that  RGC  apoptosis  was
Figure 5. Colocalization of Dexras1, neuronal nitric oxide synthase (nNOS), and C-terminal PSD95/DLG/ZO-1 ligand of neuronal nitric oxide
synthase (CAPON) after light exposure. Immunoﬂuorescence was performed to observe Dexras1 colocalization with nNOS and CAPON in
the retina at 1 day after light exposure. A-C: nNOS immunoreactivity was colocalized in Dexras1-positive cells in the retina. D-F: nNOS
immunoreactivity was colocalized in CAPON-positive cells in the retina. G-I: Dexras1 immunoreactivity was colocalized in CAPON-positive
cells in the retina. C, F, I: Merged images. Magnification, 400×. Abbreviations: GCL represents ganglion cell layer; INL represents inner
nuclear layer; ONL represents outer nuclear layer.
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140Figure 6. Inhibition of nitric oxide synthase (NOS) by L-NAME decreased the expression of cleaved caspase-3 and Dexras1. Adult rats were
injected intraperitoneally with L-NAME or PBS as a control. At 1 day after light exposure, the injured retina was prepared. A-B: western blot
analysis showed cleaved caspase-3 and Dexras1 expression in the normal retina, injured retina with PBS treated group, and injured retina with
L-NAME treated group. C-D: Quantitative analysis of A and B, respectively. Relative protein level represented a ratio between the amount
of target gene and amount of endogenous GAPDH control. Groups marked with an asterisk were significantly different from the control group.
The data are means±SEM (n=5, *p<0.05). Immunofluorescence showed colabeling of Dexras1 and cleaved caspase-3 in the retina at 1 day
after light exposure with E-G: the PBS treated group and H-J: the L-NAME treated group. G, J: Merged images. Magnification, 400×.
Abbreviations: GCL represents ganglion cell layer; INL represents inner nuclear layer; ONL represents outer nuclear layer.
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141caspase-dependent and photoreceptor cell apoptosis may be
caspase-independent. The different mechanisms of cell death
deserve further investigations.
nNOS  plays  a  key  role  in  the  light-induced  retinal
degeneration model [13]. Dexras1 binds to nNOS via the
adaptor  protein  CAPON,  which  is  a  55  kDa  protein  that
contains a C-terminal domain that binds to the PSD95/DLG/
ZO-1 domain of nNOS [18]. The ternary complex of Dexras1,
nNOS, and CAPON enables NO to S-nitrosylate NMDARs
and alters their signaling [38]. In this report, the colocalization
of  Dexras1,  nNOS,  and  CAPON  was  observed  in  RGCs,
giving evidence of the existence of a ternary complex in the
retina.  These  data  show  that  Dexras1-mediated  RGC
apoptosis may be associated with nNOS.
Pharmacological inhibition of NOS activity by L-NAME
has been investigated for its possible neuroprotective effect
on  RGCs  [26,39].  Systemic  treatment  with  NMDAR
antagonists has a similar protective effect on RGCs compared
with systemic treatment with L-NAME [40]. In the current
study,  intraperitoneal  administration  of  L-NAME  was
monitored  in  the  retina  after  light  exposure.  The  results
showed  that  L-NAME  prevented  RGCs  apoptosis  by
decreasing cleaved caspase-3 and Dexras1 expression. These
results further support the claim that Dexras1 participates in
RGC apoptosis in conjunction with activating nNOS.
In conclusion, we demonstrated that the transient high
expression of Dexras1 is localized in apoptotic RGCs and
colocalized  with  nNOS  and  CAPON.  The  NOS  inhibitor
attenuated RGC apoptosis by reducing cleaved caspase-3 and
Dexras1 expression, implicating that Dexras1-mediated RGC
damage appeared in nNOS activation. Dexras1 is a novel Ras-
like G protein that modulates multiple signaling cascades.
Further  investigations  are  necessary  to  explore  the  signal
transduction of Dexras1 in RGC apoptosis.
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